US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 1.3350
  • -0.0550-3.96%
Trading Apr 19 15:27 ET
279.51MMarket Cap-4767P/E (TTM)

Akebia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-33.46%194.62M
0.74%56.2M
-13.69%42.05M
-55.39%56.38M
-34.96%40.13M
38.19%292.48M
-3.29%55.78M
-0.09%48.71M
138.82%126.37M
17.96%61.7M
Operating revenue
-33.46%194.62M
0.74%56.2M
-13.69%42.05M
-55.39%56.38M
-34.96%40.13M
38.19%292.48M
-3.29%55.78M
-0.09%48.71M
138.82%126.37M
17.96%61.7M
Cost of revenue
-13.34%74.15M
644.33%18.67M
-52.96%18.01M
-7.08%17.28M
-37.84%19.48M
-43.21%85.57M
-107.20%-3.43M
140.10%38.28M
-64.57%18.6M
-9.43%31.34M
Gross profit
-41.78%120.47M
-36.61%37.53M
130.39%24.04M
-63.72%39.09M
-31.99%20.64M
239.32%206.92M
489.16%59.21M
-68.20%10.43M
25,681.10%107.77M
71.52%30.36M
Operating expense
-38.72%166.55M
-42.48%36.16M
-39.16%36.9M
-18.56%48.18M
-48.82%45.48M
-16.50%271.76M
-16.62%62.86M
-30.83%60.66M
-25.83%59.16M
7.52%88.85M
Selling and administrative expenses
-27.68%100.23M
-14.95%25.44M
-28.78%22.71M
-16.14%27.04M
-43.10%25.22M
-20.41%138.6M
-33.25%29.91M
-31.21%31.89M
-22.59%32.24M
7.26%44.33M
-Selling and marketing expense
-27.68%100.23M
-14.95%25.44M
-28.78%22.71M
-16.14%27.04M
-43.10%25.22M
-20.41%138.6M
-33.25%29.91M
-31.21%31.89M
-22.59%32.24M
7.26%44.33M
Research and development costs
-51.47%63.08M
-69.27%9.87M
-52.44%13.33M
-22.40%20.2M
-55.09%19.69M
-12.08%129.99M
8.60%32.1M
-30.75%28.03M
-30.06%26.03M
7.93%43.83M
Other operating expenses
1.95%3.24M
0.47%856K
16.29%864K
6.39%949K
-17.44%568K
-9.00%3.18M
-17.20%852K
-14.60%743K
-0.22%892K
-1.01%688K
Operating profit
28.95%-46.08M
137.67%1.37M
74.38%-12.87M
-118.70%-9.09M
57.55%-24.83M
75.48%-64.85M
94.42%-3.65M
8.49%-50.23M
161.26%48.61M
9.92%-58.49M
Net non-operating interest income expense
61.55%-6.03M
13.33%-1.42M
64.32%-1.41M
67.40%-1.64M
69.16%-1.56M
21.31%-15.69M
67.81%-1.64M
22.28%-3.95M
-1.51%-5.04M
-5.35%-5.06M
Non-operating interest expense
-61.55%6.03M
-13.33%1.42M
-64.32%1.41M
-67.40%1.64M
-69.16%1.56M
--15.69M
--1.64M
-22.28%3.95M
1.51%5.04M
5.35%5.06M
Other net income (expense)
101.33%182K
183.50%658K
-361.73%-212K
96.88%-440K
-84.48%176K
-667.23%-13.69M
-240.71%-788K
-81.03%81K
-1,216.21%-14.12M
604.35%1.13M
Special income (charges)
95.81%-705K
--0
84.44%-169K
97.04%-430K
---106K
---16.84M
---1.22M
---1.09M
---14.53M
--0
-Less：Restructuring and merger&acquisition
-98.86%181K
--0
-6.11%169K
-100.65%-94K
--106K
--15.93M
--1.22M
--180K
--14.53M
--0
-Less:Other special charges
-42.16%524K
--0
----
--524K
----
--906K
--0
--906K
----
----
Other non- operating income (expenses)
-71.81%887K
51.61%658K
-103.68%-43K
-102.43%-10K
-75.13%282K
30.32%3.15M
-22.50%434K
173.30%1.17M
-67.51%411K
604.35%1.13M
Income before tax
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
58.00%-26.22M
66.59%-94.23M
91.31%-6.07M
9.15%-54.1M
135.46%29.45M
10.29%-62.42M
Income tax
Net income
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
58.00%-26.22M
66.59%-94.23M
91.31%-6.07M
9.15%-54.1M
135.46%29.45M
10.29%-62.42M
Net income continuous Operations
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
58.00%-26.22M
66.59%-94.23M
91.31%-6.07M
9.15%-54.1M
135.46%29.45M
10.29%-62.42M
Minority interest income
Net income attributable to the parent company
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
58.00%-26.22M
66.59%-94.23M
91.31%-6.07M
9.15%-54.1M
135.46%29.45M
10.29%-62.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
44.89%-51.93M
110.11%614K
73.22%-14.49M
-137.94%-11.17M
58.00%-26.22M
66.59%-94.23M
91.31%-6.07M
9.15%-54.1M
135.46%29.45M
10.29%-62.42M
Basic earnings per share
46.15%-0.28
0
72.41%-0.08
-137.50%-0.06
60.00%-0.14
69.41%-0.52
90.00%-0.04
14.71%-0.29
131.37%0.16
22.22%-0.35
Diluted earnings per share
46.15%-0.28
0
72.41%-0.08
-140.00%-0.06
60.00%-0.14
69.41%-0.52
90.00%-0.04
14.71%-0.29
129.41%0.15
22.22%-0.35
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -33.46%194.62M0.74%56.2M-13.69%42.05M-55.39%56.38M-34.96%40.13M38.19%292.48M-3.29%55.78M-0.09%48.71M138.82%126.37M17.96%61.7M
Operating revenue -33.46%194.62M0.74%56.2M-13.69%42.05M-55.39%56.38M-34.96%40.13M38.19%292.48M-3.29%55.78M-0.09%48.71M138.82%126.37M17.96%61.7M
Cost of revenue -13.34%74.15M644.33%18.67M-52.96%18.01M-7.08%17.28M-37.84%19.48M-43.21%85.57M-107.20%-3.43M140.10%38.28M-64.57%18.6M-9.43%31.34M
Gross profit -41.78%120.47M-36.61%37.53M130.39%24.04M-63.72%39.09M-31.99%20.64M239.32%206.92M489.16%59.21M-68.20%10.43M25,681.10%107.77M71.52%30.36M
Operating expense -38.72%166.55M-42.48%36.16M-39.16%36.9M-18.56%48.18M-48.82%45.48M-16.50%271.76M-16.62%62.86M-30.83%60.66M-25.83%59.16M7.52%88.85M
Selling and administrative expenses -27.68%100.23M-14.95%25.44M-28.78%22.71M-16.14%27.04M-43.10%25.22M-20.41%138.6M-33.25%29.91M-31.21%31.89M-22.59%32.24M7.26%44.33M
-Selling and marketing expense -27.68%100.23M-14.95%25.44M-28.78%22.71M-16.14%27.04M-43.10%25.22M-20.41%138.6M-33.25%29.91M-31.21%31.89M-22.59%32.24M7.26%44.33M
Research and development costs -51.47%63.08M-69.27%9.87M-52.44%13.33M-22.40%20.2M-55.09%19.69M-12.08%129.99M8.60%32.1M-30.75%28.03M-30.06%26.03M7.93%43.83M
Other operating expenses 1.95%3.24M0.47%856K16.29%864K6.39%949K-17.44%568K-9.00%3.18M-17.20%852K-14.60%743K-0.22%892K-1.01%688K
Operating profit 28.95%-46.08M137.67%1.37M74.38%-12.87M-118.70%-9.09M57.55%-24.83M75.48%-64.85M94.42%-3.65M8.49%-50.23M161.26%48.61M9.92%-58.49M
Net non-operating interest income expense 61.55%-6.03M13.33%-1.42M64.32%-1.41M67.40%-1.64M69.16%-1.56M21.31%-15.69M67.81%-1.64M22.28%-3.95M-1.51%-5.04M-5.35%-5.06M
Non-operating interest expense -61.55%6.03M-13.33%1.42M-64.32%1.41M-67.40%1.64M-69.16%1.56M--15.69M--1.64M-22.28%3.95M1.51%5.04M5.35%5.06M
Other net income (expense) 101.33%182K183.50%658K-361.73%-212K96.88%-440K-84.48%176K-667.23%-13.69M-240.71%-788K-81.03%81K-1,216.21%-14.12M604.35%1.13M
Special income (charges) 95.81%-705K--084.44%-169K97.04%-430K---106K---16.84M---1.22M---1.09M---14.53M--0
-Less：Restructuring and merger&acquisition -98.86%181K--0-6.11%169K-100.65%-94K--106K--15.93M--1.22M--180K--14.53M--0
-Less:Other special charges -42.16%524K--0------524K------906K--0--906K--------
Other non- operating income (expenses) -71.81%887K51.61%658K-103.68%-43K-102.43%-10K-75.13%282K30.32%3.15M-22.50%434K173.30%1.17M-67.51%411K604.35%1.13M
Income before tax 44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M58.00%-26.22M66.59%-94.23M91.31%-6.07M9.15%-54.1M135.46%29.45M10.29%-62.42M
Income tax
Net income 44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M58.00%-26.22M66.59%-94.23M91.31%-6.07M9.15%-54.1M135.46%29.45M10.29%-62.42M
Net income continuous Operations 44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M58.00%-26.22M66.59%-94.23M91.31%-6.07M9.15%-54.1M135.46%29.45M10.29%-62.42M
Minority interest income
Net income attributable to the parent company 44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M58.00%-26.22M66.59%-94.23M91.31%-6.07M9.15%-54.1M135.46%29.45M10.29%-62.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 44.89%-51.93M110.11%614K73.22%-14.49M-137.94%-11.17M58.00%-26.22M66.59%-94.23M91.31%-6.07M9.15%-54.1M135.46%29.45M10.29%-62.42M
Basic earnings per share 46.15%-0.28072.41%-0.08-137.50%-0.0660.00%-0.1469.41%-0.5290.00%-0.0414.71%-0.29131.37%0.1622.22%-0.35
Diluted earnings per share 46.15%-0.28072.41%-0.08-140.00%-0.0660.00%-0.1469.41%-0.5290.00%-0.0414.71%-0.29129.41%0.1522.22%-0.35
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg